E75.241 Niemann-Pick disease type B

Name of the Condition

• Niemann-Pick disease type B (ICD-10 Code: E75.241)

Summary

Niemann-Pick disease type B is a rare inherited lysosomal storage disorder characterized by the abnormal accumulation of sphingomyelin and cholesterol in cells, primarily affecting the liver, spleen, and lungs. It is a subtype of Niemann-Pick disease, part of a broader group of sphingolipid metabolism disorders, and presents with variable clinical manifestations. Unlike type A, type B typically has a later onset and less severe neurological involvement, though organ dysfunction remains a key feature.

Causes

This disorder results from mutations in the SMPD1 gene, which encodes the enzyme acid sphingomyelinase. These mutations impair the enzyme's ability to break down sphingomyelin, leading to its buildup in tissues. Inheritance is autosomal recessive, meaning both copies of the gene must be mutated for the condition to manifest.

Risk Factors

• Family history of Niemann-Pick disease type B or related lysosomal storage disorders.
• Consanguineous relationships, increasing the likelihood of recessive gene mutations.
• Ethnic backgrounds with higher carrier frequencies for SMPD1 mutations.

Symptoms

• Enlarged liver and spleen (hepatosplenomegaly).
• Respiratory difficulties, including recurrent infections or shortness of breath.
• Developmental delays, particularly in motor skills.
• Muscle weakness or hypotonia.
• Thrombocytopenia (low platelet count) leading to easy bruising or bleeding.
• Growth retardation or failure to thrive in children.

Diagnosis

Diagnosis involves a combination of clinical evaluation, laboratory tests, and genetic analysis. Elevated levels of sphingomyelin in blood or tissue samples may be detected. Enzyme activity assays can confirm reduced acid sphingomyelinase levels. Genetic testing for SMPD1 mutations is definitive. Imaging studies, such as liver or spleen scans, may assess organ enlargement.

Treatment Options

Treatment focuses on managing symptoms and complications. Supportive care includes respiratory therapy for lung involvement, nutritional support for growth issues, and medications to address organ dysfunction. Hematopoietic stem cell transplantation has been explored in some cases, though its efficacy varies. Regular monitoring of organ function is essential.

Prognosis and Follow-Up

Prognosis varies, with some individuals living into adulthood with manageable symptoms. Regular follow-up with specialists, including hepatologists, pulmonologists, and geneticists, is recommended to monitor organ function and adjust care plans. Early intervention may improve outcomes, particularly for respiratory and growth-related issues.

Complications

• Progressive liver or spleen dysfunction.
• Severe respiratory complications, including pulmonary fibrosis.
• Increased risk of infections due to impaired immune function.
• Thrombocytopenia leading to bleeding disorders.
• Potential for delayed neurological symptoms in some cases.

Lifestyle & Prevention

• Avoid exposure to respiratory infections through vaccinations and hygiene practices.
• Maintain a balanced diet to support growth and organ health.
• Engage in regular physical activity as tolerated to preserve muscle strength.
• Genetic counseling is recommended for families with a history of the condition.

When to Seek Professional Help

Seek medical attention if symptoms such as unexplained organ enlargement, respiratory distress, or easy bruising occur. Prompt evaluation is important for early diagnosis and management. Regular check-ups are advised for individuals with a family history or known genetic risk.

Tips for Medical Coders

Document the presence of hepatosplenomegaly, respiratory symptoms, or developmental delays to support coding. Specify if genetic testing or enzyme assays were performed, as these may influence code assignment. Ensure documentation aligns with the clinical manifestations of type B, distinguishing it from other subtypes when applicable.